Semnur Pharmaceuticals, Inc.   Report issue

For profit Phase 3
Founded: Los Altos CA United States (2013)
Status: Acquired by Sorrento Therapeutics, Inc. (2019)

Organization Overview

First Clinical Trial
2017
NCT03372161
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Semnur Pharmaceuticals, Inc.